Dr. Benedict E. Aimua, MD

Dr. Aimua practices at Johnson City Medical Center/Niswonger Children's in Johnson City, Tennessee.

Dr. Aimua's NPI, 1962674424, was assigned on March 25, 2008. Dr. Aimua holds Tennessee license 43736.

Dr. Aimua's primary practice is Johnson City Medical Center/Niswonger Children's, at 400 N State of Franklin Rd, Johnson City, TN 37604 in Washington County. The practice phone is (423) 431-6111.

Dr. Aimua's primary practice is Johnson City Medical Center/Niswonger Children's in Johnson City, Tennessee. Dr. Aimua is also affiliated with Johnson City Medical Center. The medical group on file is Southeastern Physician Services PC. Dmand AI also links Dr. Aimua to 1 more hospital, 2 group practices and clinics, 1 home health agency, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aimua practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Aimua's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Aimua is licensed in Tennessee.

CMS data shows 1,056 Medicare services from Dr. Aimua across 7 procedure codes in 2024, for 331 Medicare patients. Medicare paid $78,197 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 331 Medicare patients who saw Dr. Aimua in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aimua's median patient age at 65, with 51% women.

In 2024, Dr. Aimua wrote 855 Medicare Part D claims for 328 patients. 88% of them were for generic drugs. CMS names the drug for 530 of them, across 22 drugs with 11 or more claims each, at $43,859 in total drug cost. In 2023, CMS named 577 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Aimua for performance year 2024, reported individually. Dr. Aimua accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Aimua from 5 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $26.